Seizert Capital Partners’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-161,998
| Closed | -$476K | – | 262 |
|
|
2018
Q2 | $476K | Hold |
161,998
| – | – | 0.02% | 161 |
|
|
2018
Q1 | $476K | Sell |
161,998
-1,013,781
| -86% | -$2.98M | 0.02% | 161 |
|
|
2017
Q4 | $3.22M | Buy |
1,175,779
+24,892
| +2% | +$68.2K | 0.12% | 83 |
|
|
2017
Q3 | $3.9M | Sell |
1,150,887
-112,073
| -9% | -$380K | 0.14% | 75 |
|
|
2017
Q2 | $3.12M | Buy |
1,262,960
+70,874
| +6% | +$175K | 0.11% | 90 |
|
|
2017
Q1 | $2.71M | Buy |
+1,192,086
| New | +$2.71M | 0.1% | 100 |
|
|
2015
Q3 | – | Sell |
-528,809
| Closed | -$3.4M | – | 215 |
|
|
2015
Q2 | $3.4M | Sell |
528,809
-28,235
| -5% | -$182K | 0.09% | 123 |
|
|
2015
Q1 | $3.92M | Sell |
557,044
-36,570
| -6% | -$257K | 0.1% | 119 |
|
|
2014
Q4 | $4.58M | Sell |
593,614
-83,419
| -12% | -$643K | 0.1% | 112 |
|
|
2014
Q3 | $5.06M | Buy |
677,033
+60,878
| +10% | +$455K | 0.1% | 105 |
|
|
2014
Q2 | $5.97M | Buy |
616,155
+398,335
| +183% | +$3.86M | 0.12% | 88 |
|
|
2014
Q1 | $1.81M | Buy |
217,820
+51,370
| +31% | +$427K | 0.04% | 95 |
|
|
2013
Q4 | $1.41M | Buy |
+166,450
| New | +$1.41M | 0.03% | 108 |
|